High materiality7/10
Prime Medicine transferred with Buy rating at Chardan
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Chardan assigned Buy on Prime Medicine with a $7 target; current price $3.25.
- Chardan Buy; $7 target; price $3.25.
Key facts
- 01
Target: $7
- 02
Posted price: $3.25
- 03
Analyst firm: Chardan Capital
- 04
Analyst: Keay Nakae
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.